Seattle startup Oisín Biotechnologies raises cash to develop therapies for age-related diseases Oisín Biotechnologies, a Seattle-based startup focused on treating aging-related diseases, raised the first close of a $15 million Series A… Read More
Oisín raises $5M to develop treatments for ‘zombie cells’ associated with age-related diseases New funding: Seattle biotech startup Oisín Biotechnologies has raised a $5 million seed round. It’s currently developing preclinical therapies that… Read More
Tech Moves: Xnor.ai taps former Auth0 leader as CEO; Microsoft adds first CVP of retail; and more Xnor.ai, an AI edge computing startup that spun out from the Allen Institute of Artificial Intelligence, has tapped former Auth0… Read More
